The efficacy of F-18-FDG PET/CT in the preoperative evaluation of pancreatic lesions

Creative Commons License

Akçam A. T., Teke Z., Sarıtaş A. G., Ulku A., Güney İ. B., Rencüzoğulları A.

ANNALS OF SURGICAL TREATMENT AND RESEARCH, cilt.98, ss.184-189, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 98
  • Basım Tarihi: 2020
  • Doi Numarası: 10.4174/astr.2020.98.4.184
  • Dergi Adı: ANNALS OF SURGICAL TREATMENT AND RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.184-189
  • Anahtar Kelimeler: Chronic pancreatitis, Pancreas, Pancreatic neoplasms, Pancreatic pseudocyst, Positron emission tomography computed tomography, POSITRON-EMISSION-TOMOGRAPHY, GLUCOSE-TRANSPORTER-1 EXPRESSION, FDG-PET, DIAGNOSIS, SURVIVAL, BENIGN, CANCER, DIFFERENTIATION, ACCUMULATION, MANAGEMENT
  • Çukurova Üniversitesi Adresli: Evet

Özet

Purpose: Since the treatment strategy for benign and malignant pancreatic lesions differ, we aimed to evaluate the clinical
value of PET/CT in the diagnosis and management of pancreatic lesions.
Methods: Ninety patients who had a histologically confirmed pancreatic lesion were studied. Receiver operating
characteristic (ROC) curve analysis was used to investigate the ability of PET/CT to differentiate malignant lesions from
benign tumors.
Results: The malignant and benign groups comprised 64 and 26 patients, respectively. Despite the similarity in the size
of primary tumors (P = 0.588), the mean maximum standardized uptake values (SUVmax) obtained from PET/CT imaging
were significantly higher in malignant lesions (9.36 ± 5.9) than those of benign tumors (1.04 ± 2.6, P < 0.001). ROC analysis
showed that the optimal SUVmax cutoff value for differentiating malignant lesions (to an accuracy of 91%; 95% confidence
interval, 83%–98%) from benign tumors was 3.9 (sensitivity, 92.2%; specificity, 84.6%).
Conclusion: PET/CT evaluation of pancreatic lesions confers advantages including fine assessment of malignant potential
with high sensitivity and accuracy using a threshold SUVmax value of 3.9.
[Ann Surg Treat Res 2020;98(4):184-189]
Key Words: Chronic pancreatitis, Pancreas, Pancreatic neoplasms, Pancreatic pseudocyst, Positron emission tomography
computed tomography